Human VAP-1

<strong>Human VAP-1</strong>_x000D_ <strong>Catalog number:</strong> B2014191_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~80 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> AOC3, Copper Amine Oxidase, HPAO, Membrane Primary Amine Oxidase, SSAO, Vascular Adhesion Protein-1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Danielli M, Thomas RC, Quinn LM, Tan BK. Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases Vasa. 2022 Nov;51(6):341-350._x000D_ 2: Hernandez-Guillamon M, Sol M, Delgado P, Garc_a-Bonilla L, Giralt D, Boada C, Penalba A, Garc_a S, Flores A, Rib_ M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke Cerebrovasc Dis. 2012;33(1):55-63._x000D_ 3: Chang SJ, Tu HP, Lai YC, Luo CW, Nejo T, Tanaka S, Chai CY, Kwan AL. Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas Diagnostics (Basel). 2020 Apr 27;10(5):256._x000D_ 4: Almulki L, Noda K, Nakao S, Hisatomi T, Thomas KL, Hafezi-Moghadam A. Localization of vascular adhesion protein-1 (VAP-1) in the human eye Exp Eye Res. 2010 Jan;90(1):26-32._x000D_ 5: Pannecoeck R, Serruys D, Benmeridja L, Delanghe JR, van Geel N, Speeckaert R, Speeckaert MM. Vascular adhesion protein-1: Role in human pathology and application as a biomarker Crit Rev Clin Lab Sci. 2015;52(6):284-300._x000D_ 6: Salmi M, Jalkanen S. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells J Exp Med. 1996 Feb 1;183(2):569-79._x000D_ 7: Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management Gastroenterology. 2013 Sep;145(3):521-36._x000D_ 8: Unzeta M, Hernndez-Guillamon M, Sun P, Sol M. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease Int J Mol Sci. 2021 Mar 25;22(7):3365._x000D_ 9: Kemik O, S_mer A, Kemik AS, Itik V, Dulger AC, Purisa S, Tuzun S. Human vascular adhesion proten-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease World J Surg Oncol. 2010 Sep 17;8:83._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/10864915">10: Salmi M, Tohka S, Jalkanen S. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear Circ Res. 2000 Jun 23;86(12):1245-51. </a>_x000D_ _x000D_ <strong>Products Related to Human VAP-1 can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>